Aurora Therapeutics

Aurora Therapeutics develops a scalable platform for personalized gene editing to treat rare genetic diseases, utilizing AI-supported CRISPR design and modular manufacturing. The company targets healthcare providers and research institutions via B2B partnerships and licensing of its proprietary technology. Its key differentiator is an "umbrella" regulatory strategy that enables the parallel development of multiple mutation-specific therapies.